Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 13, 2023
Eisai announced that it has established a digital business company Theoria technologies which will accelerate the development of a dementia ecosystem. Theoria technologies is a wholly owned subsidiary of Eisai.
read more
Wednesday, September 13, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), announced that it has received the cGMP Manufacturing Compliance Certificate, ...
read more
Friday, September 15, 2023
Jubilant HollisterStier Contract Manufacturing announced the appointment of Ian Fuller as the new Vice President of Operations.
read more
Friday, September 15, 2023
Worldwide Clinical Trials, a full-service contract research organization (CRO), announced its Early Phase Clinical Pharmacology Unit (CPU) has been awarded accreditation from the College of American Pathologists (CAP).
read more
Friday, September 15, 2023
Charles River Laboratories International, Inc. and Related Sciences, a data science-driven drug discovery firm, announced a multi-program collaboration agreement to apply Logica™ across several previously undrugged targets in the RS portfolio.
read more
Friday, September 15, 2023
Johnson & Johnson updated its brand and uniting both its medtech and pharmaceutical segments under the Johnson & Johnson brand name to demonstrate its collective power in healthcare.
read more
Friday, September 15, 2023
CordenPharma announced the inauguration of increased commercial peptide production capacity with newly-upgraded facilities at CordenPharma Colorado, the largest Solid-Phase Peptide Synthesis (SPPS) Manufacturing facility worldwide.
read more
Monday, September 18, 2023
Kindeva Drug Delivery, a global drug delivery device contract development and manufacturing organization (CDMO), announced that Brian Schubmehl has joined the company as Chief Human Resources Officer.
read more
Monday, September 18, 2023
Astrea Bioseparations, a provider of bioseparation and purification technologies announced the expansion of its manufacturing and warehousing capabilities in the US. The increased capacity reflects growing demand for the Company’s chromatography ...
read more
Tuesday, September 19, 2023
Rentschler Biopharma SE, a global contract development and manufacturing organization (CDMO) for biopharmaceuticals, announced that the company has hired Benedikt von Braunmuehl as Chief Executive Officer (CEO).
read more
Wednesday, September 20, 2023
Future Fields, a biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protein production, announced the launch of its contract development and manufacturing organization (CDMO) service.
read more
Wednesday, September 20, 2023
Emmes, a global, full-service Clinical Research Organization (CRO) announced that Peter Ronco has been named Chief Executive Officer.
read more
Wednesday, September 20, 2023
Microbiologics has announced an expansion of their Biosafety Level 3 laboratory spaces at the company’s Global Virology Center in San Diego, California. Biological Safety Levels (BSL) are ranked from BSL-1 representing the lowest risk pathogens such ...
read more
Thursday, September 21, 2023
A drug development partnership between Evecxia Therapeutics and Quotient Sciences has resulted in the successful delivery of a Phase 1 clinical testing program for Evecxia’s drug candidate EVX-101, which is in development for major depressive ...
read more
Thursday, September 21, 2023
The Montreal-based CDMO C3i Center Inc is paving the way in the cell and gene therapy industry in North American and Canada as one of a few contract development and manufacturing organizations (CDMOs) to be producing in North America and for Europe. ...
read more